Basic information Safety Related Supplier

ChemicalBook Product Catalog Biochemical Engineering Polypeptide Lanreotide Acetate

1/1

Lanreotide Acetate

$ 3.00 /3KG

Min. Order1KG
Purity99%
Cas No127984-74-1
Supply Ability100kg
Update time2019-07-12

career henan chemical co

career henan chemical co

7YR

China

show more

Chemical Properties

Product Name	Lanreotide Acetate
CAS No	127984-74-1
EC-No
Min. Order	1KG
Purity	99%
Supply Ability	100kg
Release date	2019/07/12

Lanreotide Acetate Basic information

Product Name:	Lanreotide Acetate
Synonyms:	10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14, 17-pentazacycloicosane-4-carboxamide;Somatulina;LANREOTIDE ACETATE;3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2→7)-disulfide acetate;Angiopeptin acetate
CAS:	127984-74-1
MF:	C54H69N11O10S2
MW:	0
EINECS:
Product Categories:	Amino Acids & Derivatives, Pharmaceuticals, Intermediates & Derivatives
Mol File:	127984-74-1.mol

Lanreotide Acetate Chemical Properties

storage temp.	?20°C
form	powder
color	white to off-white

Safety Information

Hazard Codes	Xn
Risk Statements	63
Safety Statements	36/37
WGK Germany	3

MSDS Information

Lanreotide Acetate Usage And Synthesis

Description	Lanreotide acetate, an octapeptide somatostatin analog, reached its first worldwide market in France for acromegaly when surgery or radiotherapy have failed to restore normal growth hormone secretion. Lanreotide is a selective inhibitor of growth hormone and reduces the secretion of growth hormone, thyrotropin, motilin and pancreatic polypeptide in humans. Lanreotide has antiproliferative properties and is reportedly in clinical trials for the prevention of restenosis following coronary artery angioplasty, for diabetic retinopathy, and as a therapy for psoriasis. Its potential for neuroendocrine tumors and hormone-responsive prostate cancer has also been demonstrated.
Originator	Beaufour-Ipsen (France)
Uses	Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma.
Brand name	Somatuline LP

show more

Company Profile Introduction

You may like

Recommended supplier

MSDS|CAS|CAS DataBase|Pricacy|Terms|About Us|New Products| Contact us|Computer Version
Chemical Book